17 April 2014
OOO Fort, a Russian company, is launching a new pharmaceutical facility outside the city of Ryazan in Central Russia later this week, the Uzrf.ru portal for Russian healthcare institutions reported .
At inception, a small workshop will open in the village of Yaltunovo; further plans are for the new project to be adding production capacity as it evolves. Longer term, the new pharma is expected to create as many as 900 new skilled local jobs.
The factory will be manufacturing nano- and biotech-based drugs to treat infectious and somatic diseases. They have been developed by Fort’s own R&D staff in collaboration with a number of leading research centers of the Russian Academy of Medical Sciences.
The Ryazan project has taken about 30 months of construction and more than $130m in investment to complete.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024